Evidence map›Paper›PMID 29654222›Full record

ArticleJournal of virology2018

Correction for Chaumorcel et al., "The Human Cytomegalovirus Protein TRS1 Inhibits Autophagy via Its Interaction with Beclin 1".

Magali Chaumorcel, Marion Lussignol, Lina Mouna, Yolaine Cavignac, Kamau Fahie, Jacqueline Cotte-Laffitte, Adam Geballe, Wolfram Brune, Isabelle Beau, Patrice Codogno and 1 more

Abstract readPublished Erratum
In one paragraph

Article in Journal of virology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

11 authors.

Magali ChaumorcelINSERM UMR984, Université Paris Sud, Faculté de Pharmacie, Châtenay-Malabry, France.
Marion LussignolINSERM UMR984, Université Paris Sud, Faculté de Pharmacie, Châtenay-Malabry, France.
Lina MounaINSERM UMR984, Université Paris Sud, Faculté de Pharmacie, Châtenay-Malabry, France.
Yolaine CavignacINSERM UMR984, Université Paris Sud, Faculté de Pharmacie, Châtenay-Malabry, France.
Kamau FahieINSERM UMR984, Université Paris Sud, Faculté de Pharmacie, Châtenay-Malabry, France.
Jacqueline Cotte-LaffitteINSERM UMR984, Université Paris Sud, Faculté de Pharmacie, Châtenay-Malabry, France.
Adam GeballeFred Hutchinson Cancer Research Center and University of Washington, Seattle, Washington, USA.
Wolfram BruneHeinrich Pette Institute, Leibniz Institute for Experimental Virology, Hamburg, Germany.
Isabelle BeauINSERM UMR984, Université Paris Sud, Faculté de Pharmacie, Châtenay-Malabry, France.
Patrice CodognoINSERM UMR984, Université Paris Sud, Faculté de Pharmacie, Châtenay-Malabry, France.
Audrey EsclatineINSERM UMR984, Université Paris Sud, Faculté de Pharmacie, Châtenay-Malabry, France.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID29654222
PMCPMC5899183

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.